Novel strategies to identify biomarkers in tuberculosis
-
Marc Jacobsen
, Jens Mattow , Dirk Repsilber and Stefan H.E. Kaufmann
Abstract
The more we learn about the immune response against tuberculosis (TB) and particularly about the features which distinguish protective immunity, disease susceptibility and pathology, the better we can define biomarkers which correlate with these different stages of infection. The most widely used biomarker in TB, which without a doubt is an important component of protective immunity, is IFNγ secreted by antigen-specific CD4 T-cells. However, the complexity of the immune response against TB makes it more than likely that additional biomarkers are required for a reliable correlate of protection. As a corollary, we assume that a set of biomarkers will be required, termed a biosignature.
©2008 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Guest Editorial
- Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines
- Highlight: 3rd Semmering Conference 2007
- Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
- Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors
- Novel strategies to identify biomarkers in tuberculosis
- Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
- Lipopolysaccharide: a tool and target in enterobacterial vaccine development
- The coming of age of virus-like particle vaccines
- Maintenance of serological memory
- Adjuvant activity of type I interferons
- Japanese encephalitis vaccines – needs, flaws and achievements
- Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
- Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age
- Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
- Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties
- Review
- RNA switches regulate initiation of translation in bacteria
- Protein Structure and Function
- Inhibition of bacterial oxidases by formamide and analogs
- Modeling of variant copies of subunit D1 in the structure of photosystem II from Thermosynechococcus elongatus
Articles in the same Issue
- Guest Editorial
- Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines
- Highlight: 3rd Semmering Conference 2007
- Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
- Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors
- Novel strategies to identify biomarkers in tuberculosis
- Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
- Lipopolysaccharide: a tool and target in enterobacterial vaccine development
- The coming of age of virus-like particle vaccines
- Maintenance of serological memory
- Adjuvant activity of type I interferons
- Japanese encephalitis vaccines – needs, flaws and achievements
- Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
- Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age
- Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
- Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties
- Review
- RNA switches regulate initiation of translation in bacteria
- Protein Structure and Function
- Inhibition of bacterial oxidases by formamide and analogs
- Modeling of variant copies of subunit D1 in the structure of photosystem II from Thermosynechococcus elongatus